White Blood Cell Count Patterns in ANCA Vasculitis

Introduction to WBC Patterns

The American College of Nephrology recommends considering concurrent infection, treatment effects, or drug-induced vasculitis variants when encountering elevated WBC counts in ANCA vasculitis patients, as elevated WBC counts are not a typical feature of the disease itself 1, 2

Levamisole-induced AAV characteristically presents with neutropenia, retiform purpuric rash, high-titre MPO ANCA positivity, and dual MPO/PR3 ANCA positivity, according to the American Journal of Kidney Diseases 1, 2
Discontinuation of the offending agent is critical to control AAV and prevent relapses in drug-induced cases, as stated by the American Journal of Kidney Diseases 1, 2

The European League Against Rheumatism notes that 15-Deoxyspergualin, an alternative remission induction agent for refractory disease, is dosed specifically until WBC count reaches a nadir of 3000/ml, then held until WBC returns to >4000/ml before repeating the cycle 3
Glucocorticoids, a cornerstone of AAV treatment, commonly cause leukocytosis as a side effect, which can confound interpretation of WBC counts, according to the American Journal of Kidney Diseases 4

The American College of Rheumatology recommends using structured clinical assessment tools like the Birmingham Vasculitis Activity Score (BVAS) to guide treatment decisions, as WBC counts are not a primary disease activity marker in ANCA vasculitis 5

The British Medical Journal advises prioritizing ruling out infection when encountering elevated WBC counts in a patient with ANCA vasculitis, as serious infections are a major cause of morbidity and mortality in AAV patients receiving immunosuppression 6